Información del artículo
Resumen
El cáncer colorrectal (CCR) es una de las neoplasias más frecuentes en los países desarrollados, y hasta un 5% de los todos casos ocurre en el contexto de un síndrome hereditario. Estas formas hereditarias demandan en muchas ocasiones un alto grado de sospecha para su diagnóstico y requieren de un manejo específico y especializado. Además, el diagnóstico del CCR hereditario tiene importantes consecuencias no sólo para el paciente, para el que existen medidas de prevención altamente efectivas, sino también para los familiares, que pueden ser portadores de la misma condición. Los avances más significativos en el campo del CCR hereditario se han producido en la caracterización del síndrome del poliposis serrada y en el diagnóstico y manejo de los pacientes con síndrome de Lynch y la poliposis adenomatosa familiar.
Palabras clave:
Cáncer colorrectal hereditario
Poliposis adenomatosa familiar
Pólipo serrado
Poliposis serrada
Síndrome de Lynch
Síndrome de poliposis hiperplásica
Abstract
Colorectal cancer (CRC) is one of the most common malignancies in developed countries, and up to 5% of all cases occur in the context of a hereditary syndrome. These hereditary forms often require a high degree of suspicion for diagnosis, as well as specific and specialized management. In addition, a diagnosis of hereditary CRC has major consequences not only for the patient, for whom there are highly effective prevention measures, but also for relatives, who may be carriers of the same condition. The most significant advances in the field of hereditary CRC have occurred in the characterization of serrated polyposis syndrome and in the diagnosis and management of patients with Lynch syndrome and familial adenomatous polyposis.
Keywords:
Hereditary colorectal cancer
Familial adenomatous polyposis
Serrated polyp
Serrated polyposis
Lynch syndrome
Hyperplastic polyposis
El Texto completo está disponible en PDF
Bibliografía
[1.]
F. Balaguer, A. Castells.
Hyperplastic polyps: are they completely innocent?.
Curr Colorectal Cancer Rep, 7 (2011), pp. 42-49
[2.]
M.J. O’Brien.
Hyperplastic and serrated polyps of the colorectum.
Gastroenterol Clin North Am, 36 (2007), pp. 947-968
[3.]
K.S. Boparai, E.M. Mathus-Vliegen, J.J. Koornstra, F.M. Nagengast, M. Van Leerdam, C.J. Van Noesel, et al.
Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study.
Gut, 59 (2010), pp. 1094-1100
[4.]
K.S. Boparai, J.B. Reitsma, V. Lemmens, T.A. Van Os, E.M. Mathus-Vliegen, J.J. Koornstra, et al.
Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome.
Gut, 59 (2010), pp. 1222-1225
[5.]
A. Rashid, P.S. Houlihan, S. Booker, G.M. Petersen, F.M. Giardiello, S.R. Hamilton.
Phenotypic and molecular characteristics of hyperplastic polyposis.
Gastroenterology, 119 (2000), pp. 323-332
[6.]
C. Sánchez-Fortuny, C. Guarinos, L. Pérez-Carbonell, C. Alenda, A. Paya, E. Rojas, et al.
Clinical and molecular features of the hyperplastic polyposis syndrome.
Gastroenterolgy, 140 (2011), pp. 1
[7.]
D.L. Edelstein, J.E. Axilbund, L. Hylind, K. Romans, M.R. Cruz-Correa, F.M. Giardiello.
High risk of colorectal cancer in hyperplastic polyposis.
Gastroenterology, 140 (2011), pp. 1
[8.]
D.L. Edelstein, J.E. Axilbund, L. Hylind, K. Romans, M.R. Cruz-Correa, F.M. Giardiello.
The natural history of hyperplastic polyposis.
Gastroenterology, 140 (2011), pp. 1
[9.]
V. Pinol, A. Castells, M. Andreu, S. Castellvi-Bel, C. Alenda, X. Llor, et al.
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
JAMA, 293 (2005), pp. 1986-1994
[10.]
H.T. Lynch, C.R. Boland, G. Gong, T.G. Shaw, P.M. Lynch, R. Fodde, et al.
Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications.
Eur J Hum Genet, 14 (2006), pp. 390-402
[11.]
C.R. Boland, S.N. Thibodeau, S.R. Hamilton, D. Sidransky, J.R. Eshleman, R.W. Burt, et al.
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Cancer Res, 58 (1998), pp. 5248-5257
[12.]
J.M. Cunningham, E.R. Christensen, D.J. Tester, C.Y. Kim, P.C. Roche, L.J. Burgart, et al.
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cancer Res, 58 (1998), pp. 3455-3460
[13.]
S. Grover, E.M. Stoffel, L. Bussone, E. Tschoegl, S. Syngal.
Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients.
Clin Gastroenterol Hepatol, 2 (2004), pp. 813-819
[14.]
C.R. Boland, M. Shike.
Report from the Jerusalem workshop on Lynch syndrome-hereditary nonpolyposis colorectal cancer.
Gastroenterology, 138 (2010), pp. 2197e1-21977e
[15.]
N.M. Lindor, K. Rabe, G.M. Petersen, R. Haile, G. Casey, J. Baron, et al.
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
JAMA, 293 (2005), pp. 1979-1985
[16.]
L. Perez-Carbonell, C. Guarinos, M. Rodriguez-Soler, C. Sanchez-Fortuny, L. Sempere-Robles, C. Ruiz-Ponte, et al.
Comparison between universal immunohistochemistry for mismatch repair proteins vs revised Bethesda guidelines in the detection of patients with Lynch syndrome.
Gastroenterology, 140 (2011), pp. 1
[17.]
M. Rodríguez-Soler, L. Pérez-Carbonell, C. Guarinos, C. Ruiz-Ponte, A. Brea, A. Castillejo, et al.
Differential features of colorectal cancer in patients with probable non-sporadic mismatch repair defficiency without germline mutation.
Gastroenterology, 140 (2011), pp. 1
[18.]
M.S. Pino, M. Mino-Kenudson, B.M. Wildemore, A. Ganguly, J. Batten, I. Sperduti, et al.
Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas.
J Mol Diagn, 11 (2009), pp. 238-247
[19.]
M. Redston, R.H. Lash.
High yield of Lynch syndrome screening in pre-cancerous colorectal polyps: a study of 898 patients.
Gastroenterology, 140 (2011), pp. 1
[20.]
L. Capelle, C.M. Den Hoed, N.C. Van Grieken, G.A. Meijer, E.J. Kuipers, H.F. Vasen.
Gastric cancer in Lynch syndrome: is surveillance justified?.
Gastroenterology, 140 (2011), pp. 1
[21.]
H.J. Jarvinen, M. Aarnio, H. Mustonen, K. Aktan-Collan, L.A. Aaltonen, P. Peltomaki, et al.
Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
Gastroenterology, 118 (2000), pp. 829-834
[22.]
S. Parry, A.K. Win, B. Parry, F.A. Macrae, L.C. Gurrin, J.M. Church, et al.
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
Gut, 60 (2011), pp. 950-957
[23.]
S. Gulikers, E. Rondagh, Y. Vanlingen, E. Gomez-Garcia, H.F. Vasen, A. Masclee, et al.
High prevalence of nonpolypoid colorectal neoplasms in patients with Lynch syndrome: potential implications for surveillance strategies.
Gastroenterology, 140 (2011), pp. 1
[24.]
H.F. Vasen, G. Moslein, A. Alonso, S. Aretz, I. Bernstein, L. Bertario, et al.
Guidelines for the clinical management of familial adenomatous polyposis (FAP).
Gut, 57 (2008), pp. 704-713
[25.]
P. Friederich, A.E. De Jong, L.M. Mathus-Vliegen, E. Dekker, H.H. Krieken, J. Dees, et al.
Risk of developing adenomas and carcinomas in the ileal pouch in patients with familial adenomatous polyposis.
Clin Gastroenterol Hepatol, 6 (2008), pp. 1237-1242
[26.]
R. Pendlimari, E.J. Dozois, J.Y. Wang, D. Leonard, M.C. McKenna, R.R. Cima, et al.
Long-term risk of neoplastic change in ileal pouches created for familial adenomatous polyposis.
Gastroenterology, 140 (2011), pp. 1
[27.]
E. Jang, L.R. Zukerberg, R.D. Odze, M. Gala, P.B. Kelsey, D.G. Forcione, et al.
The efficacy of endoscopic ampullectomy in familial adenomatous polyposis syndrome.
Gastroenterology, 140 (2011), pp. 1
Copyright © 2011. Elsevier España S.L.. Todos los derechos reservados
